Editorial Board: Arch Pharm (9/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202370018
- Publication type:
- Article
Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 9
Results: 14
1
2
Unraveling the chemical profile, antioxidant, enzyme inhibitory, cytotoxic potential of different extracts from Astragalus caraganae.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300263
- By:
- Publication type:
- Article
3
Cover Picture: Arch Pharm (9/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202370017
- Publication type:
- Article
4
In silico characterization of ligand–receptor interactions for U‐47700, N,N‐didesmethyl‐U‐47700, U‐50488 at mu‐ and kappa‐opioid receptors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300256
- By:
- Publication type:
- Article
5
An overview of the privileged synthetic heterocycles as urease enzyme inhibitors: Structure–activity relationship.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300252
- By:
- Publication type:
- Article
6
Synthesis and biological profile of benzoxazolone derivatives.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300245
- By:
- Publication type:
- Article
7
Novel hydrazone‐isatin derivatives as potential EGFR inhibitors: Synthesis and in vitro pharmacological profiling.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300244
- By:
- Publication type:
- Article
8
Targeting the binding pocket of the fluorophore 8‐anilinonaphthalene‐1‐sulfonic acid in the bacterial enzyme MurA.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300237
- By:
- Publication type:
- Article
9
Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300205
- By:
- Publication type:
- Article
10
Multitargeting in cardioprotection: An example of biaromatic compounds.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300196
- By:
- Publication type:
- Article
11
Ruthenium polypyridine complexes containing prenyl groups as antibacterial agents against Staphylococcus aureus through a membrane‐disruption mechanism.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300175
- By:
- Publication type:
- Article
12
Melatonin–vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300149
- By:
- Publication type:
- Article
13
Proapoptotic effects of halogenated bis‐phenylthiourea derivatives in cancer cells.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300105
- By:
- Publication type:
- Article
14
Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 9, p. 1, doi. 10.1002/ardp.202300097
- By:
- Publication type:
- Article